UnitedHealth Group Incorporated Stock Price Targets

Comprehensive analysis of short, mid, and long-term price targets for UnitedHealth Group Incorporated (UNH).

Back to Analysis Hub

Give me a comprehensive price target analysis for UnitedHealth Group Incorporated (UNH).

Below is a comprehensive price-target analysis for UnitedHealth Group Incorporated (UNH) as of 2025-10-10, followed by the execution of the requested horizontal price-target lines on the chart.

First, the price-target lines drawn on the active chart

  • Low Target: 198.00 (green, support-style)
  • Median Target: 357.50 (blue, neutral/central target)
  • High Target: 626.00 (red, resistance/upper target)
  • Lines are extended 30 days into the future from today (2025-11-09)
  • Ticker: UNH

Line drawing summary (executed):

  • Low Target 198.00: green line from 2025-10-10 to 2025-11-09
  • Median Target 357.50: blue line from 2025-10-10 to 2025-11-09
  • High Target 626.00: red line from 2025-10-10 to 2025-11-09

Executive Summary

  • Investment thesis: UNH remains a premier, diversified healthcare company with strong cash generation, a robust balance sheet, and a dependable dividend. The stock trades at a forward P/E around 12.3x with a dividend yield of 2.39%, and it benefits from secular demand in health services and payer administration. The consensus target dispersion is wide, reflecting a broad range of scenarios for the stock’s growth, margin trajectory, and potential multiple re-rating.
  • Overall price outlook: Neutral-to-moderately constructive. The current price (~367.69) sits near the consensus median target (~357.50) with substantial upside potential if earnings quality improves and the macro/policy environment remains favorable. A high-end target of 626.00 suggests meaningful upside under a bullish scenario, while a low target of 198.00 implies risks if earnings quality erodes or policy/regulatory headwinds intensify.

Fundamental Analysis Key Valuation and Health Metrics

  • Current price: 367.69
  • Market capitalization: 333.01B
  • Enterprise value: 392.26B
  • Trailing P/E: 15.93
  • Forward P/E: 12.30
  • Price-to-Book: 3.51
  • Return on Equity (ROE): 21.65%
  • Return on Assets (ROA): 6.46%
  • Profit margin: 5.04%
  • Gross margin: 20.84%
  • Operating margin: 4.61%
  • Debt to equity: 75.58
  • Total cash: 31.02B
  • Total debt: 79.19B
  • Dividend yield: 2.39% (five-year average: 1.47%)
  • Beta: 0.478 (lower-beta profile)

Interpretation:

  • The forward multiple (12.3x) versus trailing (15.9x) implies modest multiple expansion potential if growth and margin stability improve relative to the last reported period.
  • A debt-to-equity ratio around 75% reflects substantial leverage, but UNH carries ample cash and strong cash flow, providing headroom for debt service, buybacks, and dividends.
  • The stock’s low beta and solid dividend yield support a core-position thesis in a defensively oriented market.

Earnings Analysis Recent Earnings Performance

  • Latest quarter (2025-06-30) highlights:
    • Total revenue: 111.616B
    • Normalized EBITDA: 6.234B
    • EBITDA (as reported): 6.193B
    • Operating income: 5.15B
    • Net income from continuing operations: 3.406B
    • Diluted EPS: 3.74
    • Basic EPS: 3.76
    • Tax rate for calculations: 0.125
    • Unusual items (net): negative 41.0M (with similar exclusions for goodwill)
    • Diluted average shares: ~910M
  • Prior quarter (2025-03-31) and earlier show higher normalized EBITDA and diluted EPS, with Net Income from continuing operations around 6.29B and diluted EPS near 6.85 in 2025-03-31, suggesting a softer quarter in the latest reporting period after normalization and adjustments.

EPS Trends

  • Trend snapshot (from EPS Trend data):
    • 0q (current quarter): 2.87
    • +1q: 2.06
    • 0y (TTM perspective): 16.24
    • +1y: 17.98
  • GAAP vs. normalized view:
    • The GAAP Diluted EPS in the earnings summary shows a notably higher figure in earlier quarters (e.g., 6.85 in 2025-03-31) than the latest quarter (3.74 in 2025-06-30), indicating a mix of ongoing earnings strength with material one-time or non-recurring items driving differences.
    • The EPS Trend table presents a much lower current-quarter figure (2.87) than the year-ago levels, underscoring a volatile quarterly pattern and potential normalization/one-time factors in the base period.

EPS Revisions

  • Revisions momentum (periods shown):
    • 0q: Up last 7 days: 0; Up last 30 days: 0; Down last 30 days: 1; Down last 7 days: 0
    • +1q: Up last 7 days: 0; Up last 30 days: 1; Down last 30 days: 0; Down last 7 days: 0
    • 0y: Up last 7 days: 0; Up last 30 days: 0; Down last 30 days: 1; Down last 7 days: 0
    • +1y: Up last 7 days: 1; Up last 30 days: 1; Down last 30 days: 3; Down last 7 days: 0
  • Interpretation:
    • The latest revisions show more downward revisions across the +1y horizon (3 downgrades in the last 30 days) and relatively modest upward revisions in some other periods. This leans toward a cautious sentiment on longer-term earnings, albeit with some near-term/upward revisions in select periods.

Technical Analysis (Last 60 Days)

  • 50-day Moving Average (MA): The latest MA is around 313.5 (as of 2025-10-09). The current price (~367.7 on 2025-10-09/10) sits well above the 50-day MA, signaling a bullish near-term trend.
  • RSI (14): Latest reading ~78.8 (overbought territory), suggesting potential near-term pullback risk or consolidation.
  • MACD (12,26,9): Latest MACD ~12.9 with a Signal of ~12.5, signaling ongoing bullish momentum, though the histogram is narrowing slightly, consistent with a possible pause after a strong move.
  • Interpretation: Trend is upward with strong price action and momentum, but risk of short-term consolidation or pullback exists given overbought RSI.

Analyst Consensus & Price Targets

  • Current price: 367.69
  • Coverage: 24 analysts
  • Targets (low/median/high):
    • Low: 198.00
    • Median: 357.50
    • High: 626.00
  • Target mean: 357.00
  • Interpretation:
    • The median and mean targets sit slightly below or near the current price, suggesting a modest near-term risk/flat to small-downside bias in consensus.
    • The high target (626.00) indicates a substantial upside in a bull scenario, while the low (198.00) implies significant downside risk if earnings or policy dynamics deteriorate.
    • The dispersion implies that investors should consider scenarios across a wide range of outcomes.

Catalysts and Drivers

  • Positive catalysts:
    • Continued strength in Medicare Advantage and commercial healthcare services segments
    • Cost discipline, improving operating leverage, and potential margin expansion
    • Strong free cash flow enabling buybacks/dividends
    • Potential strategic bolt-ons that enhance scale and service mix
  • Negative catalysts:
    • Regulatory/policy shifts affecting pricing, reimbursement, or patient mix
    • Competitive intensity in managed care and health services
    • Macro headwinds impacting healthcare utilization or premium growth

Price Target Analysis (Short, Mid, Long-Term)

  • Short-Term (3 months): 357.50
    • Rationale: At around 367.69 today, the near-term price action may drift toward the median target as the market digests the latest quarterly results. The 357.50 target acts as a near-term anchor for valuation if earnings normalization or incremental guidance remains mixed. Key drivers include quarterly earnings visibility, continued cash generation, and near-term macro/healthcare policy signals.
    • Potential drivers: ongoing cost controls, steady enrollment growth in Medicare Advantage, and continued cash flow strength; risk of a pullback if RSI-driven short-term weakness accelerates.
  • Mid-Term (12 months): 357.50
    • Rationale: The consensus median target around 357.50 suggests a fair-to-moderate upside/downside path over the next year, assuming continued revenue growth with stable margins and no material surprises. A base-case valuation multiple around forward P/E 12.0–12.5x could support a similar price level given modest earnings growth and a resilient cash profile.
    • Potential drivers: earnings stabilization, potential margin improvement, and buyback activity; risk of multiple compression if growth slows or policy/regulatory pressures intensify.
  • Long-Term (3+ years): 626.00
    • Rationale: The high target represents a bull-case scenario where UNH experiences meaningful earnings acceleration, margin expansion, and multiple re-rating driven by strong free cash flow, scalable services, and continued favorable healthcare trends. This path requires sustained execution and favorable policy/regulatory dynamics that support higher earnings growth and investor confidence.
    • Potential drivers: continued improvement in operating margins, efficiency gains, favorable timing for share repurchases, and a more favorable policy backdrop; risks include policy shifts, competition, and macro headwinds that suppress earnings growth or multiple expansion.

Key Risks & Opportunities

  • Major Risks:
    • Regulatory and policy changes affecting pricing/reimbursement in both public and private plans
    • Structural competition in managed care and external health services spaces
    • Potential severity of macro swings impacting healthcare utilization and premium growth
    • Execution risk in realizing efficiency gains and margin expansion
  • Key Opportunities:
    • Leverage of scale in Medicare Advantage and focused healthcare services
    • Ongoing cost discipline and potential margin expansion
    • Strong balance sheet enabling continued buybacks and dividend growth
    • Potential M&A or strategic partnerships to broaden service offerings and customer retention

Investment Recommendation

  • Recommendation: Hold
  • Time horizon: 12–24 months
  • Rationale:
    • The stock trades near the consensus median target with a modest near-term path to a flat-to-low-downside return on base-case earnings expectations.
    • The high end of the target distribution implies meaningful upside potential if earnings and margins stabilize and expand, alongside multiple re-rating.
    • The low end indicates meaningful downside risk if earnings or policy dynamics deteriorate.
  • Expected return potential (12–24 months):
    • Base-case: roughly flat to slight negative modest returns (approximately -2% to +5% range depending on quarterly performance and multiple changes)
    • Bull-case: material upside toward the 626.00 target in a favorable earnings/policy environment (potential +70%+ from current levels over multi-year horizons)
    • Bear-case: risk of decline toward the low target near 198.00 in stressed scenarios (approximately -46% from current levels)

Technical Takeaways for Traders

  • Price action: UNH remains in an uptrend with price well above the 50-day MA (313.5), indicating continued bullish momentum.
  • Momentum: RSI around 78.8 indicates overbought conditions in the near term; MACD positive and rising supports continued upside but watch for a potential consolidation.
  • Trading stance: For those with a slightly longer horizon, the stock offers upside potential if earnings momentum and policy tailwinds align; near-term traders should monitor RSI and headline-driven catalysts for possible pullbacks.

Data Sources and Notes

  • Price, market data, and analyst targets are as of 2025-10-10.
  • Earnings, EPS trends, and revisions are drawn from the provided quarterly figures and revisions datasets.
  • Technical indicators (50-day MA, RSI, MACD) reflect the most recent data points provided (late 2025-09 to 2025-10 window).

Appendix: Key data points used

  • Price targets (analyst consensus):
    • Low: 198.00
    • Median: 357.50
    • High: 626.00
    • Current price: 367.69
    • Analyst count: 24
  • Fundamental snapshot:
    • Market cap: 333.01B
    • EV: 392.26B
    • Forward P/E: 12.30
    • P/B: 3.51
    • ROE: 21.65%
    • ROA: 6.46%
    • Profit margin: 5.04%
    • Gross margin: 20.84%
    • Operating margin: 4.61%
    • Debt/Equity: 75.58
    • Cash: 31.02B
    • Debt: 79.19B
    • Dividend yield: 2.39%
    • Beta: 0.478
  • Earnings snapshot (latest quarter):
    • Revenue: 111.616B
    • Normalized EBITDA: 6.234B
    • EBITDA: 6.193B
    • Net income (continuing ops): 3.406B
    • Diluted EPS: 3.74
    • Tax rate: 12.5%
  • EPS Trend (selected figures):
    • Current 0q: 2.87427
    • +1q: 2.05869
    • 0y: 16.23554
    • +1y: 17.97713
  • EPS Revisions (selected):
    • 0q: down last 30 days = 1 downgrade
    • +1q: up last 30 days = 1 upgrade
    • +1y: down last 30 days = 3 downgrades
  • Technicals:
    • 50-day MA (latest): ~313.5
    • RSI (14): ~78.8
    • MACD: 12.9 (signal 12.5)

Would you like me to add a probability-weighted scenario model (base/bull/bear) with explicit probability inputs to quantify a range of potential 12- to 24-month outcomes? I can also build a concise slide-ready version of this analysis if you need.

Chart is loading...